Global Infectious Disease Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Infectious Disease Diagnostics Market
Infectious disease diagnostics are the procedures for identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making right medical decisions. Infectious diseases caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. Infectious disease diagnostics can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods.
The key drivers for the growth of the infectious disease diagnostics market increase in the prevalence of dengue, malaria, and HIV, rise in the preference for rapid diagnosis, increase in government funding for the establishment of diagnostic centers, and technological advancements in diagnostic procedures expected to fuel the infectious disease diagnostics market. Furthermore, increase in the R&D activities for newer assays, changing demographics around the globe, and advances in healthcare infrastructure are expected to boost the infectious disease diagnostics market. However, high cost for the diagnostic procedures, lack of awareness about the novel diagnostic procedures, dearth of skilled professionals to perform diagnostic tests, and lack of reimbursement policies for several diagnostic test might hamper the infectious disease diagnostics market growth over the forecast period.
The infectious disease diagnostics market has been segmented on the basis of test type, technique type, product type, infection type, and the end-user
Based on the test type, infectious disease diagnostics market has been segmented into following:
Geographically, global infectious disease diagnostics market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global infectious disease diagnostics market followed by Europe and Asia-Pacific. The largest share of North-America region is due to increase in the prevalence of infectious diseases especially in U.S. According to UNAIDS, in 2012, about 1.3 Mn patients were diagnosed with HIV in the U.S. These statistics are likely to increase over the coming years, if suitable treatment options are not provided in time. The European region is expected to emerge as significant market owing to improved healthcare infrastructure, and increase in prevalence of bacterial and viral diseases (according to WHO European Region, at the end of 2015, about 13.3 Mn people live with chronic hepatitis B, an estimated 15 Mn people with hepatitis C, and more than 2 Mn people with HIV), which are expected to fuel the growth of the infectious disease diagnostics market in European region. Moreover, Asia-Pacific is a key region for the growth of global infectious disease diagnostics during the forecast period, due to the high prevalence of infectious diseases, and increasing in healthcare expenditure. Moreover, due to increase in incidence and prevalence of infectious diseases such as bacterial infections and sexually transmitted diseases and rise in population expected to drive significant growth of the infectious disease diagnostics market in Asia-Pacific region.
Some of the players in global infectious disease diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Thermo Fischer Scientific (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson & Company (U.S.), and DiaSorin S.p.A. (Italy) to name a few.
In 2016, Abbott unveiled Alinity, its unified family of innovative next-generation diagnostics system across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics
In 2015, Bio-Rad FDA has approved Bio-Rad’s BioPlex 2200 human immunodeficiency virus (HIV) Antigen-Antibody assay, used for detection of HIV antibodies and HIV antigens
In 2014, DiaSorin launched the new molecular diagnostic test for the detection of Toxoplasmosis
REPORT OUTLINE:
Infectious disease diagnostics are the procedures for identification and characterization of the causative agent of an infectious disease with the aid of diagnostic tools. These diagnostics provide crucial information for making right medical decisions. Infectious diseases caused by various micro-organisms such as viruses, bacteria, fungi, and parasites. Infectious diseases transmitted from person to person through either indirect or direct contact. Infectious diseases such as bacterial infections, fungal infections, and viral infections such as respiratory diseases, HPV, HIV, measles, malaria, dengue, cholera, and hepatitis B and C are gradually spreading worldwide. Infectious disease diagnostics can be based solely on clinical presentation or more rigorous diagnostic tests, such as microscopy, biochemical screens, culturing of an infectious agent, and molecular methods.
The key drivers for the growth of the infectious disease diagnostics market increase in the prevalence of dengue, malaria, and HIV, rise in the preference for rapid diagnosis, increase in government funding for the establishment of diagnostic centers, and technological advancements in diagnostic procedures expected to fuel the infectious disease diagnostics market. Furthermore, increase in the R&D activities for newer assays, changing demographics around the globe, and advances in healthcare infrastructure are expected to boost the infectious disease diagnostics market. However, high cost for the diagnostic procedures, lack of awareness about the novel diagnostic procedures, dearth of skilled professionals to perform diagnostic tests, and lack of reimbursement policies for several diagnostic test might hamper the infectious disease diagnostics market growth over the forecast period.
The infectious disease diagnostics market has been segmented on the basis of test type, technique type, product type, infection type, and the end-user
Based on the test type, infectious disease diagnostics market has been segmented into following:
- Imaging test
- Magnetic Resonance Imaging (MRI)
- X-ray
- Computed tomography (C.T)
- Laboratory tests
- Blood test
- Urine test
- Stool test
- Spinal tap
- Throat swabs
- Biopsies
- Others
- Assay kits and consumables
- Instruments
- Services
- Viral
- Bacterial
- CNS
- Fungal
- Cardiovascular
- Sexually transmitted infectious diseases
- Gastrointestinal
- Others
- Hospitals
- Diagnostic laboratories
- Home healthcare
- Ambulatory clinics
- Others
Geographically, global infectious disease diagnostics market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the global infectious disease diagnostics market followed by Europe and Asia-Pacific. The largest share of North-America region is due to increase in the prevalence of infectious diseases especially in U.S. According to UNAIDS, in 2012, about 1.3 Mn patients were diagnosed with HIV in the U.S. These statistics are likely to increase over the coming years, if suitable treatment options are not provided in time. The European region is expected to emerge as significant market owing to improved healthcare infrastructure, and increase in prevalence of bacterial and viral diseases (according to WHO European Region, at the end of 2015, about 13.3 Mn people live with chronic hepatitis B, an estimated 15 Mn people with hepatitis C, and more than 2 Mn people with HIV), which are expected to fuel the growth of the infectious disease diagnostics market in European region. Moreover, Asia-Pacific is a key region for the growth of global infectious disease diagnostics during the forecast period, due to the high prevalence of infectious diseases, and increasing in healthcare expenditure. Moreover, due to increase in incidence and prevalence of infectious diseases such as bacterial infections and sexually transmitted diseases and rise in population expected to drive significant growth of the infectious disease diagnostics market in Asia-Pacific region.
Some of the players in global infectious disease diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Thermo Fischer Scientific (U.S.), Abbott Laboratories (U.S.), Bio-Rad Laboratories Inc. (U.S.), Becton, Dickinson & Company (U.S.), and DiaSorin S.p.A. (Italy) to name a few.
In 2016, Abbott unveiled Alinity, its unified family of innovative next-generation diagnostics system across immunoassay, clinical chemistry, point of care, hematology, blood and plasma screening, and molecular diagnostics
In 2015, Bio-Rad FDA has approved Bio-Rad’s BioPlex 2200 human immunodeficiency virus (HIV) Antigen-Antibody assay, used for detection of HIV antibodies and HIV antigens
In 2014, DiaSorin launched the new molecular diagnostic test for the detection of Toxoplasmosis
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET INTRODUCTION
2.1. Global Infectious Disease Diagnostics Market– Taxonomy
2.2. Global Infectious Disease Diagnostics Market–Definitions
2.2.1. Test Type
2.2.2. Product Type
3. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamics – Factors Impact Analysis
3.6. Global Infectious Disease Diagnostics Market– Recent Product Launches
4. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Imaging Test
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Magnetic Resonance Imaging (MRI)
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Laboratory Tests
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Biopsies
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Assay Kits and Consumables
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Instruments
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY INFECTION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Viral
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Bacterial
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Fungal
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Sexually Transmitted Infectious Diseases
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Gastrointestinal
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic laboratories
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Home Healthcare
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Ambulatory Clinics
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Imaging Test
10.1.1.2. Magnetic Resonance Imaging (MRI)
10.1.1.3. X-ray
10.1.1.4. Computed tomography (C.T)
10.1.1.5. Laboratory Tests
10.1.1.5.1. Blood Tests
10.1.1.5.2. Urine Tests
10.1.1.5.3. Stool Tests
10.1.1.5.4. Spinal Tap
10.1.1.5.5. Throat Swabs
10.1.1.6. Biopsies
10.1.1.7. Others
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Assay Kits and Consumables
10.1.2.2. Instruments
10.1.2.3. Services
10.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Viral
10.1.3.2. Bacterial
10.1.3.3. Fungal
10.1.3.4. Sexually Transmitted Infectious Diseases
10.1.3.5. Gastrointestinal
10.1.3.6. Others
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Diagnostic laboratories
10.1.4.3. Home Healthcare
10.1.4.4. Ambulatory Clinics
10.1.4.5. Others
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Country, 2017 – 2023
10.1.7. North America Infectious Disease Diagnostics Market Dynamics – Trends
11. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Imaging Test
11.1.1.2. Magnetic Resonance Imaging (MRI)
11.1.1.3. X-ray
11.1.1.4. Computed tomography (C.T)
11.1.1.5. Laboratory Tests
11.1.1.5.1. Blood Tests
11.1.1.5.2. Urine Tests
11.1.1.5.3. Stool Tests
11.1.1.5.4. Spinal Tap
11.1.1.5.5. Throat Swabs
11.1.1.6. Biopsies
11.1.1.7. Others
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Assay Kits and Consumables
11.1.2.2. Instruments
11.1.2.3. Services
11.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Viral
11.1.3.2. Bacterial
11.1.3.3. Fungal
11.1.3.4. Sexually Transmitted Infectious Diseases
11.1.3.5. Gastrointestinal
11.1.3.6. Others
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Diagnostic laboratories
11.1.4.3. Home Healthcare
11.1.4.4. Ambulatory Clinics
11.1.4.5. Others
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
11.1.7. Europe Infectious Disease Diagnostics Market Dynamics – Trends
12. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Imaging Test
12.1.1.2. Magnetic Resonance Imaging (MRI)
12.1.1.3. X-ray
12.1.1.4. Computed tomography (C.T)
12.1.1.5. Laboratory Tests
12.1.1.5.1. Blood Tests
12.1.1.5.2. Urine Tests
12.1.1.5.3. Stool Tests
12.1.1.5.4. Spinal Tap
12.1.1.5.5. Throat Swabs
12.1.1.6. Biopsies
12.1.1.7. Others
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Assay Kits and Consumables
12.1.2.2. Instruments
12.1.2.3. Services
12.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Viral
12.1.3.2. Bacterial
12.1.3.3. Fungal
12.1.3.4. Sexually Transmitted Infectious Diseases
12.1.3.5. Gastrointestinal
12.1.3.6. Others
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Diagnostic laboratories
12.1.4.3. Home Healthcare
12.1.4.4. Ambulatory Clinics
12.1.4.5. Others
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends
13. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Imaging Test
13.1.1.2. Magnetic Resonance Imaging (MRI)
13.1.1.3. X-ray
13.1.1.4. Computed tomography (C.T)
13.1.1.5. Laboratory Tests
13.1.1.5.1. Blood Tests
13.1.1.5.2. Urine Tests
13.1.1.5.3. Stool Tests
13.1.1.5.4. Spinal Tap
13.1.1.5.5. Throat Swabs
13.1.1.6. Biopsies
13.1.1.7. Others
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Assay Kits and Consumables
13.1.2.2. Instruments
13.1.2.3. Services
13.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Viral
13.1.3.2. Bacterial
13.1.3.3. Fungal
13.1.3.4. Sexually Transmitted Infectious Diseases
13.1.3.5. Gastrointestinal
13.1.3.6. Others
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Diagnostic laboratories
13.1.4.3. Home Healthcare
13.1.4.4. Ambulatory Clinics
13.1.4.5. Others
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
13.1.7. Latin America Infectious Disease Diagnostics Market Dynamics – Trends
14. MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Imaging Test
14.1.1.2. Magnetic Resonance Imaging (MRI)
14.1.1.3. X-ray
14.1.1.4. Computed tomography (C.T)
14.1.1.5. Laboratory Tests
14.1.1.5.1. Blood Tests
14.1.1.5.2. Urine Tests
14.1.1.5.3. Stool Tests
14.1.1.5.4. Spinal Tap
14.1.1.5.5. Throat Swabs
14.1.1.6. Biopsies
14.1.1.7. Others
14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Assay Kits and Consumables
14.1.2.2. Instruments
14.1.2.3. Services
14.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Viral
14.1.3.2. Bacterial
14.1.3.3. Fungal
14.1.3.4. Sexually Transmitted Infectious Diseases
14.1.3.5. Gastrointestinal
14.1.3.6. Others
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Diagnostic laboratories
14.1.4.3. Home Healthcare
14.1.4.4. Ambulatory Clinics
14.1.4.5. Others
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
14.1.7. MEA Infectious Disease Diagnostics Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
15.2.2. bioMérieux SA (France)
15.2.3. Thermo Fischer Scientific (U.S.)
15.2.4. Abbott Laboratories (U.S.)
15.2.5. Bio-Rad Laboratories Inc. (U.S.)
15.2.6. Becton, Dickinson & Company (U.S.)
15.2.7. DiaSorin S.p.A. (Italy)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET INTRODUCTION
2.1. Global Infectious Disease Diagnostics Market– Taxonomy
2.2. Global Infectious Disease Diagnostics Market–Definitions
2.2.1. Test Type
2.2.2. Product Type
3. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Infectious Disease Diagnostics Market Dynamics – Factors Impact Analysis
3.6. Global Infectious Disease Diagnostics Market– Recent Product Launches
4. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TEST TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Imaging Test
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Magnetic Resonance Imaging (MRI)
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Laboratory Tests
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Biopsies
5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Assay Kits and Consumables
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Instruments
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Services
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY INFECTION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Viral
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Bacterial
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Fungal
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Sexually Transmitted Infectious Diseases
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Gastrointestinal
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Others
7.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
8. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Diagnostic laboratories
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Home Healthcare
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Ambulatory Clinics
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Region, 2017 – 2023
10. NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Imaging Test
10.1.1.2. Magnetic Resonance Imaging (MRI)
10.1.1.3. X-ray
10.1.1.4. Computed tomography (C.T)
10.1.1.5. Laboratory Tests
10.1.1.5.1. Blood Tests
10.1.1.5.2. Urine Tests
10.1.1.5.3. Stool Tests
10.1.1.5.4. Spinal Tap
10.1.1.5.5. Throat Swabs
10.1.1.6. Biopsies
10.1.1.7. Others
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Assay Kits and Consumables
10.1.2.2. Instruments
10.1.2.3. Services
10.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Viral
10.1.3.2. Bacterial
10.1.3.3. Fungal
10.1.3.4. Sexually Transmitted Infectious Diseases
10.1.3.5. Gastrointestinal
10.1.3.6. Others
10.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Hospitals
10.1.4.2. Diagnostic laboratories
10.1.4.3. Home Healthcare
10.1.4.4. Ambulatory Clinics
10.1.4.5. Others
10.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.5.1. U.S.
10.1.5.2. Canada
10.1.6. North America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type, By Infection Type, By End User, and Country, 2017 – 2023
10.1.7. North America Infectious Disease Diagnostics Market Dynamics – Trends
11. EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Imaging Test
11.1.1.2. Magnetic Resonance Imaging (MRI)
11.1.1.3. X-ray
11.1.1.4. Computed tomography (C.T)
11.1.1.5. Laboratory Tests
11.1.1.5.1. Blood Tests
11.1.1.5.2. Urine Tests
11.1.1.5.3. Stool Tests
11.1.1.5.4. Spinal Tap
11.1.1.5.5. Throat Swabs
11.1.1.6. Biopsies
11.1.1.7. Others
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Assay Kits and Consumables
11.1.2.2. Instruments
11.1.2.3. Services
11.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Viral
11.1.3.2. Bacterial
11.1.3.3. Fungal
11.1.3.4. Sexually Transmitted Infectious Diseases
11.1.3.5. Gastrointestinal
11.1.3.6. Others
11.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Hospitals
11.1.4.2. Diagnostic laboratories
11.1.4.3. Home Healthcare
11.1.4.4. Ambulatory Clinics
11.1.4.5. Others
11.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.5.1. Germany
11.1.5.2. UK
11.1.5.3. France
11.1.5.4. Spain
11.1.5.5. Italy
11.1.5.6. Russia
11.1.5.7. Poland
11.1.5.8. Rest of Europe
11.1.6. Europe Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
11.1.7. Europe Infectious Disease Diagnostics Market Dynamics – Trends
12. ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Imaging Test
12.1.1.2. Magnetic Resonance Imaging (MRI)
12.1.1.3. X-ray
12.1.1.4. Computed tomography (C.T)
12.1.1.5. Laboratory Tests
12.1.1.5.1. Blood Tests
12.1.1.5.2. Urine Tests
12.1.1.5.3. Stool Tests
12.1.1.5.4. Spinal Tap
12.1.1.5.5. Throat Swabs
12.1.1.6. Biopsies
12.1.1.7. Others
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Assay Kits and Consumables
12.1.2.2. Instruments
12.1.2.3. Services
12.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Viral
12.1.3.2. Bacterial
12.1.3.3. Fungal
12.1.3.4. Sexually Transmitted Infectious Diseases
12.1.3.5. Gastrointestinal
12.1.3.6. Others
12.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Hospitals
12.1.4.2. Diagnostic laboratories
12.1.4.3. Home Healthcare
12.1.4.4. Ambulatory Clinics
12.1.4.5. Others
12.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.5.1. Japan
12.1.5.2. China
12.1.5.3. India
12.1.5.4. ASEAN
12.1.5.5. Australia & New Zealand
12.1.5.6. Rest of Asia-Pacific
12.1.6. Asia-Pacific Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
12.1.7. Asia-Pacific Infectious Disease Diagnostics Market Dynamics – Trends
13. LATIN AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Imaging Test
13.1.1.2. Magnetic Resonance Imaging (MRI)
13.1.1.3. X-ray
13.1.1.4. Computed tomography (C.T)
13.1.1.5. Laboratory Tests
13.1.1.5.1. Blood Tests
13.1.1.5.2. Urine Tests
13.1.1.5.3. Stool Tests
13.1.1.5.4. Spinal Tap
13.1.1.5.5. Throat Swabs
13.1.1.6. Biopsies
13.1.1.7. Others
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Assay Kits and Consumables
13.1.2.2. Instruments
13.1.2.3. Services
13.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Viral
13.1.3.2. Bacterial
13.1.3.3. Fungal
13.1.3.4. Sexually Transmitted Infectious Diseases
13.1.3.5. Gastrointestinal
13.1.3.6. Others
13.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Hospitals
13.1.4.2. Diagnostic laboratories
13.1.4.3. Home Healthcare
13.1.4.4. Ambulatory Clinics
13.1.4.5. Others
13.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.5.1. Brazil
13.1.5.2. Mexico
13.1.5.3. Argentina
13.1.5.4. Venezuela
13.1.5.5. Rest of Latin America
13.1.6. Latin America Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
13.1.7. Latin America Infectious Disease Diagnostics Market Dynamics – Trends
14. MIDDLE EAST & AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1.1. Test Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Imaging Test
14.1.1.2. Magnetic Resonance Imaging (MRI)
14.1.1.3. X-ray
14.1.1.4. Computed tomography (C.T)
14.1.1.5. Laboratory Tests
14.1.1.5.1. Blood Tests
14.1.1.5.2. Urine Tests
14.1.1.5.3. Stool Tests
14.1.1.5.4. Spinal Tap
14.1.1.5.5. Throat Swabs
14.1.1.6. Biopsies
14.1.1.7. Others
14.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Assay Kits and Consumables
14.1.2.2. Instruments
14.1.2.3. Services
14.1.3. Infection Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Viral
14.1.3.2. Bacterial
14.1.3.3. Fungal
14.1.3.4. Sexually Transmitted Infectious Diseases
14.1.3.5. Gastrointestinal
14.1.3.6. Others
14.1.4. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.4.1. Hospitals
14.1.4.2. Diagnostic laboratories
14.1.4.3. Home Healthcare
14.1.4.4. Ambulatory Clinics
14.1.4.5. Others
14.1.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.5.1. Gulf Cooperation Council (GCC) Countries
14.1.5.2. Israel
14.1.5.3. South Africa
14.1.5.4. Rest of MEA
14.1.6. MEA Infectious Disease Diagnostics Market- Opportunity Analysis Index - By Test Type, By Product Type Type, By Infection Type, By End User, and Country, 2017 – 2023
14.1.7. MEA Infectious Disease Diagnostics Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. F. Hoffmann-La Roche Ltd. (Switzerland)
15.2.2. bioMérieux SA (France)
15.2.3. Thermo Fischer Scientific (U.S.)
15.2.4. Abbott Laboratories (U.S.)
15.2.5. Bio-Rad Laboratories Inc. (U.S.)
15.2.6. Becton, Dickinson & Company (U.S.)
15.2.7. DiaSorin S.p.A. (Italy)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS